- Min.Order :1 Kilogram
- Purity: 99.5
- Payment Terms : L/C,D/P,T/T,,MoneyGram
Keywords
4-[(4-cyanophenyl)-(1, 2, 4-triazol-1-yl)methyl]benzonitrile 4,4'-(1h-1,2,4-Triazol-1-Ylmethylene)Bisbenzonitrile; Lelrozol; 4,4'-(1h-1,2,4-Triazol-1-Ylmethylene) Bis-Benzonitrile; Femara; Letrozol; Letrazole 99.5%
Quick Details
- Appearance:White or white crystalline powder.
- Application: There is concern that long term use may lead to osteoporosis,and breast cancer
- PackAge:Aluminum Foil Bag
- ProductionCapacity:100|Kilogram|Year
- Storage:protect from direct light,keep dry
- Transportation:normal
Superiority:
Function and Usage: Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. Side effects include signs and symptoms of hypoestrogenism. There is concern that long term use may lead to osteoporosis, which is why prescriptions of Letrozole are often accompanied by prescriptions of osteoporosis-fighting medications such as bisphosphonates
Details:
Appearance: White or off-white crystalline powder
melt point: 181-183°C
You Might Also Like
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View